{
    "nct_id": "NCT03928288",
    "official_title": "Novel, Non-Hormonal Therapy for the Treatment of Chronic Pain Due to Endometriosis in Adolescent and Adult Women",
    "inclusion_criteria": "* Female with surgically-confirmed endometriosis\n* Age 15 years to 40 years\n* Current use ≥ 2 months duration of hormonal therapy such as combined oral contraceptives, norethindrone acetate, or levonorgestrel intrauterine device\n* Current pelvic pain (score ≥ 3 on Visual Analog Scale, where 0 represents absence of pain and 10 indicates unbearable pain) present for ≥ 14 days/month over the 2 months prior to study enrollment\n* Willingness to comply with visit schedule and protocol\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 15 Years\nMust have maximum age of 40 Years",
    "exclusion_criteria": "* Pre-menarche or post-menopause\n* Contraindications to cabergoline (e.g., cardiac valve disorder; pulmonary, pericardial, retroperitoneal fibrotic disorder; hypersensitivity to ergot derivatives; uncontrolled hypertension)\n* Significant mental or chronic systemic illness that might confound pain assessment or the ability to complete the study\n* Pregnant, breastfeeding, or planning to become pregnant in the next 6 months\n* Impaired liver function (ALT > 2x normal) or liver disease\n* Breast cancer, current or previous\n* Thromboembolic disease, current or previous\n* Use of other drugs that affect dopamine (e.g., phenothiazines, metoclopramide, butyrophenones)",
    "miscellaneous_criteria": ""
}